My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Compounds may keep virus from entering cells; may accelerate drug development Researchers found 53 existing drugs that may keep the Ebola virus from entering human cells, a key step in…
The Lancet: Basic medical care of Ebola patients is neglected and must improve The widespread misconception that there are no proven treatments for Ebola virus disease has meant that simple…
" Zinc deficiency affects about 2 billion people worldwide, including an estimated 40 percent of the elderly in the United States – who are also among the most likely Americans to…
PUBLIC RELEASE DATE: 12-Nov-2014 Scientists have demonstrated for the first time that a single-dose, needleless Ebola vaccine given to primates through their noses and lungs protected them against infection for…
[youtube https://www.youtube.com/watch?v=lnOJ0Qp5Xis] Discuss: Avoidance of Compassionate therapies ( JAMA ) Serotherapy ZMAPP ( MB003 ) Melatonin Rutin Vit. C methylprednisolone Weaponized Ebola / Marburg * Citations upon Request Medical researchers…
"can completely protect monkeys against a lethal dose of Ebola virus up to 5 days after infection" Public Release: 29-Aug-2014 A leading U.S. Ebola researcher from the University of Texas…
18 Jan 2013 | 02:08 GMT | Posted by Helen Shen | In the first study of its kind, the US Centers for Disease Control and Prevention (CDC) unveiled statistics…
Contact: Caree Vander Linden caree.vanderlinden@us.army.mil US Army Medical Research Institute of Infectious Diseases A new Ebola virus study resulting from a widespread scientific collaboration has shown promising preliminary results,…
Contact: Jason Socrates Bardi jason.bardi@ucsf.edu 415-502-4608 University of California - San Francisco Global research effort identifies 'Bas-Congo' virus as the cause of small, isolated outbreak in 2009 IMAGE:Charles Chiu, MD,…
You must be logged in to post a comment.